1. Dear Drugs-Forum readers: We are a small non-profit that runs one of the most read drug information & addiction help websites in the world. We serve over 4 million readers per month, and have costs like all popular websites: servers, hosting, licenses and software. To protect our independence we do not run ads. We take no government funds. We run on donations which average $25. If everyone reading this would donate $5 then this fund raiser would be done in an hour. If Drugs-Forum is useful to you, take one minute to keep it online another year by donating whatever you can today. Donations are currently not sufficient to pay our bills and keep the site up. Your help is most welcome. Thank you.
    PLEASE HELP
  1. Alfa
    PSYCHEDELIC DRUGS HAVE A LONG HISTORY

    The psychedelic drugs used by Woodstock-era hippies and some of today's
    rave-going teens have a far-reaching history in medicine.

    Hundreds of years ago, American Indians experimented with psychedelic plants
    like the peyote cactus, which they embraced as a tool for religious
    exploration and spiritual ecstasy.

    Mexicans ate certain hallucinogenic mushrooms in search of a higher
    consciousness and doorways to "psychotherapeutic healing."

    During the mid-20th century, scientists began studies aimed at tapping into
    psychedelic drugs' potential to be useful in conjunction with psychotherapy.
    American and European studies conducted during the 1950s and early 1960s
    showed a promising future for psychedelic drugs in the medical
    establishment.

    Some psychiatrists believed the drugs could be especially useful in helping
    patients tap into repressed memories and cope with past abuse or traumatic
    events. But their progress came to a grinding halt when widespread use of
    LSD, a synthetic hallucinogenic drug, came to prominence during the 1960s.

    After that, tougher state and federal drug laws and public fears over the
    rise of recreational drug use made it difficult to get research funding for
    similar studies, said James Bakalar, an attorney who lectures in the
    department of psychiatry at the Harvard Medical School in Massachusetts.

    Valuable research and potential treatments have been lost as a result, he
    said. "There has to be a better understanding of not just the risks but also
    the possible value," said Bakalar, who co-authored a book in the late 1990s
    that called for further scientific research on the potential benefits of LSD
    as a therapeutic drug. "Both sides of the story have to be told," he said.

    That may happen now, with Dr. Michael Mithoefer's work in examining the
    potential role of the designer drug Ecstasy in treating people suffering
    from post-traumatic stress disorder.

    It is believed that in a medically controlled environment, psychedelic drugs
    can work much like a high-octane truth serum, causing people to open up
    about, and deal with, things they wouldn't ordinarily be comfortable talking
    about.

    Bakalar noted, however, that the psychiatric community remains hesitant to
    integrate psychedelic drugs into therapy because the process of recovering
    traumatic memories is fraught with the potential to "create false memories
    and illusion."
    Source: Post and Courier, The (Charleston, SC)

Comments

To make a comment simply sign up and become a member!